Iveric Bio Inc reports results for the quarter ended in December - Earnings Summary

IVERIC bio

24/02/2022 14:32

* Iveric Bio Inc  ISEE.OQ  reported a quarterly adjusted
loss
of 29 cents​​ per share for the quarter ended in December. The
mean expectation of five analysts for the quarter was for a loss
of 25 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Iveric Bio Inc's reported EPS for the quarter was a loss
of 29
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Iveric Bio Inc shares had fallen by 15.3% this quarter.
    * The company reported a quarterly loss of $33.03 million.
    * Wall Street's median 12-month price target for Iveric Bio
Inc is
$25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated February 24 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated